N. Drury

Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Encoding the Tumor Antigen 5T4 (TroVax) Given Alongside Chemotherapy Induces Potent Immune Responses

N. Habib, J. Nicholls, M. Carroll, 2007, Clinical Cancer Research.

Vaccination of Prostate Cancer Patients With Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax): A Phase 2 Trial

R. Amato, S. Saxena, S. Naylor, 2008, Journal of immunotherapy.

Vaccination of Colorectal Cancer Patients with Modified Vaccinia Ankara Delivering the Tumor Antigen 5T4 (TroVax) Induces Immune Responses which Correlate with Disease Control: A Phase I/II Trial

M. Carroll, J. Valle, R. Hawkins, 2006, Clinical Cancer Research.

An MVA-based Vaccine Targeting the Oncofetal Antigen 5T4 in Patients Undergoing Surgical Resection of Colorectal Cancer Liver Metastases

J. Drijfhout, P. Stern, D. Burt, 2008, Journal of immunotherapy.

Evidence of a role for a non‐matrix‐type metalloproteinase activity in the shedding of syndecan‐1 from human myeloma cells

I. Holen, P. Croucher, P. Hargreaves, 2001, British journal of haematology.

Vaccination of colorectal cancer patients with TroVax given alongside chemotherapy (5-fluorouracil, leukovorin and irinotecan) is safe and induces potent immune responses

M. Carroll, R. Hawkins, I. Redchenko, 2008, Cancer Immunology, Immunotherapy.

Vaccination of Patients With Metastatic Renal Cancer With Modified Vaccinia Ankara Encoding the Tumor Antigen 5T4 (TroVax) Given Alongside Interferon-α

F. Thistlethwaite, R. Hawkins, S. Naylor, 2009, Journal of immunotherapy.

Vaccination of renal cell cancer patients with TroVax (modified vaccinia Ankara delivering the tumor antigen 5T4) plus IFNα: A phase II trial

F. Thistlethwaite, S. Naylor, R. Harrop, 2008 .

Activity of MVA 5T4 alone or in combination with either interleukin-2 (IL-2) or interferon-α (IFN) in patients (Pts) with metastatic renal cell cancer (MRCC)

R. Amato, J. Willis, R. Harrop, 2007 .

A vaccinia-based vaccine (TroVax) targeting the oncofetal antigen 5T4 administered before and after surgical resection of colorectal cancer liver metastases: Phase II trial.

P. Stern, D. Burt, R. Hawkins, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.